Challenges of Affordability and Access

Many individuals seeking weight loss support are confronted with the high costs of medications such as Ozempic and Monjaro, which can significantly impact their ability to continue treatment. For instance, one user's monthly supply could reach $1,600, and when her insurance ceased covering it, she faced the possibility of losing access altogether. This financial burden is compounded by systemic issues in healthcare coverage, particularly affecting marginalized communities, which see a disparity in access to these necessary treatments. The emotional toll includes feelings of frustration and anger at a system that should support health rather than hinder it.